Clincosm LogoSign in Get a demo

ovarian cancer recurrent

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Fluzopril Combined With Apatinib
  • (no location specified)
Oct 22, 2023

Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

Recruiting
  • Ovarian Cancer Recurrent
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023

Ovarian Cancer Recurrent Trial in Sutton, London (Niraparib oral capsule, SBRT)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Niraparib oral capsule
  • SBRT
  • Sutton, Surrey, United Kingdom
  • +1 more
Aug 10, 2023

Ovarian Cancer Recurrent Trial in Birmingham (M4344+Niraparib)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 5, 2023

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Shanghai, Shanghai, China
    Huadong Hospital Affiliated to Fudan University
Jun 30, 2022

Ovarian Cancer Recurrent Trial in Pittsburgh (Rintatolimod, Pembrolizumab, Cisplatin)

Recruiting
  • Ovarian Cancer Recurrent
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital of UPMC
Mar 3, 2022

Ovarian Cancer Recurrent Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion)

Recruiting
  • Ovarian Cancer Recurrent
  • microtransplantation, HLA-mismatched donor peripheral stem cell infusion
  • Beijing, Beijing, China
    The third medical center of PLA General Hospital
Oct 26, 2021

Ovarian Cancer Recurrent Trial in Uppsala (radical surgery with HIPEC)

Recruiting
  • Ovarian Cancer Recurrent
  • radical surgery with HIPEC
  • Uppsala, Sweden
    Uppsala University Hopsital
Oct 1, 2021

Ovarian Cancer Recurrent Trial in Czechia (DCVAC/OvCa, Standard of Care Chemotherapy)

Completed
  • Ovarian Cancer Recurrent
  • DCVAC/OvCa
  • Standard of Care Chemotherapy
  • Brno, Czechia
  • +7 more
Apr 20, 2021

Ovarian Cancer Recurrent Trial in Leiden (Tumor Infiltrating Lymphocytes (TIL), Interferon Alfa 2A, Carboplatin)

Recruiting
  • Ovarian Cancer Recurrent
  • Tumor Infiltrating Lymphocytes (TIL)
  • +3 more
  • Leiden, ZH, Netherlands
    Leiden University Medical Center
Mar 30, 2021

Ovarian Cancer Recurrent Trial in India (Doxorubicin Hydrochloride Liposome Injection)

Completed
  • Ovarian Cancer Recurrent
  • Doxorubicin Hydrochloride Liposome Injection
  • Hyderabad, Andhra Pradesh, India
  • +14 more
Nov 19, 2019

Ovarian Cancer Recurrent Trial in Paris (Lenalidomide)

Completed
  • Ovarian Cancer Recurrent
  • Paris, France
    Hopital Tenon
Mar 15, 2016

Ovarian Cancer Recurrent Trial in United States (EP-100, Paclitaxel)

Completed
  • Ovarian Cancer Recurrent
  • Greenbrae, California
  • +14 more
Jun 9, 2014